Pharmacy Medical News about community pharmacist-initiated screening program;osteoporosis

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Community pharmacist-initiated screening program for osteoporosis: Randomized controlled trial
Osteoporosis International, 06/10/09

Yuksel N et al. – A pharmacist screening program as described in this study doubled the number of patients tested for osteoporosis. Nevertheless, many patients eligible for bone mineral density (BMD) did not receive appropriate care suggesting more intensive interventions are needed.

Methods

Aim was to determine the effect of a community pharmacist screening program on testing and treatment of osteoporosis
262 pts meeting BMD testing guidelines:
- Men or women aged ≥65 yrs or 50–64 yrs with one major risk factor including previous fracture
- Family history of osteoporosis
- Glucocorticoids for >3 mo, or
- Early menopause
  were allocated to intervention (129) or control (133)
Intervention: printed materials, education, and quantitative ultrasound
Primary outcome: a composite endpoint of BMD or prescription for osteoporosis medication within 4 mo

Results

Primary endpoint of BMD or osteoporosis treatment was achieved by 22% pts vs 11% controls
This was driven by BMD testing (22% vs 10% for controls)
Calcium intake increased more among intervention pts than controls (30% vs 19%)
No effect on knowledge or quality of life

<< Previous
Phase III noninferiority trial comparing irinotecan with...

Next >>
The Incorporation of Income and Leisure in Health State...